{"id":2053304,"date":"2023-10-03T00:12:01","date_gmt":"2023-10-03T04:12:01","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/fda-seeking-to-bring-lab-developed-tests-under-its-authority\/"},"modified":"2023-10-03T00:18:05","modified_gmt":"2023-10-03T04:18:05","slug":"fda-seeking-to-bring-lab-developed-tests-under-its-authority","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/fda-seeking-to-bring-lab-developed-tests-under-its-authority\/","title":{"rendered":"FDA wants to regulate lab-developed tests."},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"&quot;\"><div class=\"counts mashsbcount\">12<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Ffda-seeking-to-bring-lab-developed-tests-under-its-authority%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=2053304&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><blockquote>\n<h2>The FDA&#8217;s Proposed Rule to Regulate Lab-Developed Tests Sparks Controversy<\/h2>\n<p>The U.S. Food and Drug Administration (FDA) has recently proposed a rule that \u200cwould bring laboratory-developed tests (LDTs) under its regulatory authority. This decision has sparked controversy, especially considering the\u2062 Trump administration&#8217;s opposition to \u200bFDA regulation of\u200d COVID-19 tests during the pandemic.<\/p>\n<p>LDTs\u2062 are \u2064testing services \u200bdeveloped by clinical labs\u200d and hospitals, designed and used within a single laboratory \u2063for clinical purposes. Unlike commercially manufactured tests, \u2064LDTs are\u200b created\u200d to fulfill unmet clinical needs or when commercial \u200btests are unavailable.<\/p>\n<div class=\"my-5\">According to the Association for Molecular Pathology, these tests play a crucial\u200d role in early diagnosis and monitoring\u200b of patient \u200btreatment.<\/div>\n<blockquote>\n<h3>Related Stories<\/h3>\n<ul>\n<li><a href=\"http:\/\/www.theepochtimes.com\/article\/fda-found-bacterial-contamination-at-novo-nordisk-diabetes-pill-manufacturing-facility-5498640?ea_src=author_manual&#038;ea_med=related_stories\">FDA Found Bacterial Contamination \u2064at\u2062 Novo Nordisk Diabetes Pill Manufacturing\u200d Facility<\/a><\/li>\n<li><a href=\"http:\/\/www.theepochtimes.com\/health\/scientists-move-closer-to-potential-blood-test-for-detecting-long-covid-5498708?ea_src=author_manual&#038;ea_med=related_stories\">Scientists Move Closer to Potential Blood Test for Detecting Long COVID<\/a><\/li>\n<\/ul>\n<\/blockquote>\n<p>These tests are used to measure or detect substances in the body, such \u200cas glucose, \u200dproteins, cholesterol, or DNA, according to the FDA.<\/p>\n<div class=\"my-5\">Previously, LDTs were not required\u2062 to\u200c have FDA\u2064 approval for marketing, \u200bunlike commercially developed\u200c tests. However, the proposed \u200drule aims to\u2064 change that. <\/p>\n<h2>Safety\u200b Concerns<\/h2>\n<p> The FDA&#8217;s \u200drule is aimed \u2063at ensuring the safety and effectiveness of\u200c these tests, which are \u2063increasingly used \u200bin healthcare decisions. The agency has\u2063 raised concerns about the accuracy and performance of some LDTs compared to FDA-authorized tests.<\/p><\/div>\n<p>The FDA is worried that \u200cinaccurate test results could lead to unnecessary or delayed\u2062 treatment, <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/us-border-too-open-right-now-warns-new-yorks-hochul\/\" title=\"New York's Hochul warns: US border currently too open.\">potentially causing harm<\/a> to \u200dpatients. Interestingly, the Trump administration had opposed FDA regulation of lab-developed tests, but this requirement was lifted in 2020.<\/p>\n<div class=\"my-5\">According to The \u200cNew York Times, this \u200bderegulatory action aimed to better prepare for future pandemics while maintaining quality and accuracy. However,\u200b during\u2063 the early stages of the COVID-19 outbreak, lab-developed tests became crucial \u2063after faulty tests\u2062 from the \u2063U.S. Centers for Disease Control and Prevention caused delays in widespread testing. <\/p>\n<h2>FDA&#8217;s New \u2064Rules<\/h2>\n<p> The FDA&#8217;s proposed rule \u200dacknowledges that lab-developed tests have evolved and are now used more widely, impacting a larger and more diverse population.<\/p><\/div>\n<p>The FDA\u200b Commissioner, Dr. Robert M. Califf, emphasized \u200cthe importance of accurate and valid \u200dtest results, as they significantly\u200c influence medical decisions. The agency\u2062 cited instances where\u2064 lab-developed tests\u200b led to inappropriate therapies, improper treatment, and incorrect diagnoses.<\/p>\n<div class=\"my-5\">While testing \u200dlaboratories are regulated by the Centers for Medicare \u2063and Medicaid Services, they \u200cdo not evaluate test \u200caccuracy\u2062 or\u2062 <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/fda-seeking-to-bring-lab-developed-tests-under-its-authority\/\" title=\"FDA wants to regulate lab-developed tests.\">require \u2063adverse event reporting<\/a>, as reported by\u2062 Axios.<\/div>\n<p>The proposed rule would classify lab-developed tests as\u2064 in vitro diagnostic \u200dproducts (IVDs) and bring them under the Federal\u2064 Food, \u200bDrug,\u200c and \u200bCosmetic Act. \u200bThis\u2064 would allow the FDA to treat these tests \u200blike medical devices\u200d and enhance its oversight.<\/p>\n<div class=\"my-5\">According to Axios, the FDA plans to phase in regulation\u200b over five years, aiming to \u2062reduce healthcare costs associated with ineffective or unsafe\u2064 tests. <\/p>\n<h2>FDA Overstepping \u2064Authority<\/h2>\n<p> The Center\u200d for Science in the Public Interest (CSPI) supports the FDA&#8217;s proposed rule, stating that oversight of\u2064 lab-developed \u200dtests\u200d would ensure \u200creliable results. The CSPI commends\u2064 the FDA for \u2062including tests for rare diseases in the regulation to protect patients from\u200b inaccurate results.<\/p><\/div>\n<p>However, the American Clinical Laboratory Association (ACLA) opposes the FDA&#8217;s decision, arguing that the \u2064FDA lacks the statutory authority \u2064to regulate \u2063lab-developed tests as medical devices. The ACLA believes that any expansion of the FDA&#8217;s role should be tailored by Congress to fit the\u2063 unique characteristics of lab-developed tests.<\/p>\n<p>In \u200cthe past, the FDA faced industry opposition when attempting to regulate lab-developed tests. Although lawmakers started working on legislation\u200d in 2018, progress\u200d has been \u2062slow.<\/p>\n<\/blockquote>\n<p> <\/p>\n<h2> What are the main concerns raised by opponents of the FDA&#8217;s proposed rule to regulate LDTs?<\/h2>\n<p><span>  New rule would make it mandatory for\u200d all LDTs to undergo FDA review and obtain \u200bmarketing authorization before they can be used clinically. The rule would require labs to submit their LDTs to \u200cthe FDA for \u2063evaluation, \u200cincluding\u200b evidence of analytical\u200d and\u200b clinical validity, as \u2063well as data on test performance and reliability.<\/p>\n<p>Opponents of the proposed rule argue that it would stifle innovation and hinder the ability\u200d of \u200dlabs\u200c to quickly develop and deploy tests in \u2064response to <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/secy-blinken-discusses-omicron-variant-in-south-africa\/\" title=\"Secy. Blinken discusses Omicron variant in South Africa\">emerging health threats<\/a>. They argue that\u2062 the\u2063 FDA&#8217;s \u2064review process is time-consuming and costly, which could delay the availability of important tests during <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/idaho-churchgoers-sue-police-city-government-after-being-arrested-for-not-wearing-masks-outside\/\" title=\"Idaho Churchgoers Sue Police, City Government After Being Arrested For Not Wearing Masks Outside\">public health emergencies<\/a>.<\/p>\n<p>Proponents of the\u2062 rule, on the other hand, believe \u2064that FDA\u200d oversight is necessary to ensure the quality and accuracy of \u2063LDTs. They argue that some labs have been\u200c offering tests without sufficient evidence of\u200d their performance, leading to false results and potentially endangering patient \u200bsafety.<\/p>\n<p>The COVID-19 pandemic has highlighted the importance of accurate and reliable\u200d testing, and the role that LDTs can play in addressing public health \u2062crises. The FDA&#8217;s proposed rule comes at\u200c a time when the country is grappling with the challenges of \u2062widespread testing and\u200d the need for\u200d timely \u2062and accurate results.<\/p>\n<p>The controversy \u2063surrounding the \u200cFDA&#8217;s proposed rule reflects \u200ba broader debate about the\u2063 appropriate\u200c level of regulatory oversight for LDTs. While regulation can provide \u2062assurance of test accuracy \u2064and reliability, it must also strike a balance with the need for \u200dinnovation \u2063and timely access to tests.<\/p>\n<p>The FDA is seeking public \u200dinput \u200con the proposed rule, and stakeholders\u200d from \u200cvarious sectors, including laboratories, healthcare \u2062providers, patient advocacy \u2064groups, and \u200cindustry\u200d associations, have been actively engaged in\u200b the\u200c debate. It remains to be seen how the \u200dFDA will address\u200c the concerns\u2064 raised by opponents and whether any modifications will be made to the\u2064 rule in response\u2063 to public feedback.<\/p>\n<p>In conclusion, the FDA&#8217;s proposed rule to regulate LDTs has sparked controversy regarding the appropriate\u2062 level of regulatory oversight for \u2062these tests. While\u200b the FDA aims\u2062 to ensure the safety and effectiveness \u2063of \u2063LDTs, opponents argue that \u200bthe rule could stifle innovation and hinder the rapid development of \u200ctests during \u200c<a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/refusing-to-comply-with-future-mask-mandates-isnt-enough-we-need-a-federal-ban\/\" title=\"Federal ban needed for future mask mandates.\">public health\u2064 emergencies<\/a>. The debate \u2062surrounding this issue highlights the need to\u2063 strike a balance\u200c between regulation and\u2062 innovation in order to best serve the interests of patients and\u2064 public health.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The FDA proposed a rule to regulate lab-developed tests, which the Trump administration opposed during the pandemic. LDTs are testing services created by clinical labs and hospitals, not commercially manufactured.<\/p>\n","protected":false},"author":186,"featured_media":2053305,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[543],"tags":[],"class_list":["post-2053304","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-the-epoch-times"],"fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2053304","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/186"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=2053304"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2053304\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2053305"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=2053304"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=2053304"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=2053304"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}